Search research articles
Contact Us
Filters
Showing results (1-10 of 133) with videos related to
Page
of 14
Sort By:
Vascular Pharmacology
|
December 3, 2014
The role of the osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the pathogenesis of pulmonary arterial hypertension
Allan Lawrie
Cardiovascular Research
|
July 4, 2025
Assessing pulmonary artery stiffening with ultrasonography: a step forward for the assessment of pulmonary hypertension due to left heart disease?
Merve Keles, Allan Lawrie
Pharmacology & Therapeutics
|
July 5, 2016
From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease
Sarah Dawson, Allan Lawrie
European Heart Journal
|
November 19, 2025
Revisiting prostaglandin biology in pulmonary arterial hypertension: targeting the EP4/ANXA2 axis
Merve Keles, Allan Lawrie
The Journal of Clinical Investigation
|
June 1, 2021
Frataxin and endothelial cell senescence in pulmonary hypertension
Allan Lawrie, Sheila E Francis
Trends in Molecular Medicine
|
December 20, 2016
Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension
A A Roger Thompson, Allan Lawrie
Nature Cardiovascular Research
|
February 26, 2026
A blood biomarker to specifically identify idiopathic pulmonary arterial hypertension
Merve Keles, Martin R Wilkins, Allan Lawrie
Frontiers in Medicine
|
June 22, 2018
Circulating Protein Biomarkers in Systemic Sclerosis Related Pulmonary Arterial Hypertension: A Review of Published Data
Peter M Hickey, Allan Lawrie, Robin Condliffe
European Heart Journal Supplements : Journal of the European Society of Cardiology
|
December 21, 2019
Screening strategies for pulmonary arterial hypertension
David G Kiely, Allan Lawrie, Marc Humbert
Circulation Research
|
April 28, 2022
The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure
Olivier Boucherat, Vineet Agrawal, Allan Lawrie, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 133) with videos related to
Sort By:
Page
of 14
Vascular Pharmacology
|
December 3, 2014
The role of the osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the pathogenesis of pulmonary arterial hypertension
Allan Lawrie
Cardiovascular Research
|
July 4, 2025
Assessing pulmonary artery stiffening with ultrasonography: a step forward for the assessment of pulmonary hypertension due to left heart disease?
Merve Keles, Allan Lawrie
Pharmacology & Therapeutics
|
July 5, 2016
From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease
Sarah Dawson, Allan Lawrie
European Heart Journal
|
November 19, 2025
Revisiting prostaglandin biology in pulmonary arterial hypertension: targeting the EP4/ANXA2 axis
Merve Keles, Allan Lawrie
The Journal of Clinical Investigation
|
June 1, 2021
Frataxin and endothelial cell senescence in pulmonary hypertension
Allan Lawrie, Sheila E Francis
Trends in Molecular Medicine
|
December 20, 2016
Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension
A A Roger Thompson, Allan Lawrie
Nature Cardiovascular Research
|
February 26, 2026
A blood biomarker to specifically identify idiopathic pulmonary arterial hypertension
Merve Keles, Martin R Wilkins, Allan Lawrie
Frontiers in Medicine
|
June 22, 2018
Circulating Protein Biomarkers in Systemic Sclerosis Related Pulmonary Arterial Hypertension: A Review of Published Data
Peter M Hickey, Allan Lawrie, Robin Condliffe
European Heart Journal Supplements : Journal of the European Society of Cardiology
|
December 21, 2019
Screening strategies for pulmonary arterial hypertension
David G Kiely, Allan Lawrie, Marc Humbert
Circulation Research
|
April 28, 2022
The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure
Olivier Boucherat, Vineet Agrawal, Allan Lawrie, et al.
Page
of 14